London, UK – Partners4Access (P4A) is excited to announce that Managing Partner Sophie Schmitz will be attending the highly anticipated Cell & Gene Meeting on the Mesa 2024, set to take place from October 7-9, 2024 in Phoenix, Arizona. This premier annual event brings together leading figures from across the gene and cell therapy sectors to discuss the latest advances in the field and explore innovative solutions for patient access to cutting-edge treatments.
As a global expert in market access for orphan drugs and gene therapies, Sophie Schmitz’s presence at the conference underscores P4A’s commitment to staying at the forefront of the rapidly evolving gene therapy landscape. With the increasing number of cell and gene therapies gaining approval, ensuring that patients have timely access to these transformative treatments is more critical than ever.
The Cell & Gene Meeting on the Mesa provides a unique platform for networking with industry leaders, researchers, and policymakers, fostering meaningful discussions around regulatory, reimbursement, and access challenges in the gene and cell therapy space. Sophie will actively engage in these discussions, sharing insights on how P4A is driving innovation in access solutions and supporting clients to navigate the complexities of launching advanced therapies in global markets.
About Sophie Schmitz: Sophie Schmitz is a Managing Partner at Partners4Access, a consultancy dedicated to providing market access solutions for orphan drugs, cell, and gene therapies. With over 20 years of experience in the pharmaceutical industry, Sophie has been a leading voice in shaping access strategies for gene therapies, working closely with manufacturers, payers, and other stakeholders to ensure that patients can benefit from these breakthrough treatments.
About Partners4Access: Partners4Access (P4A) is a global consultancy specializing in market access for orphan drugs, gene therapies, and other rare disease treatments. P4A’s expertise lies in navigating the unique challenges of launching and accessing innovative therapies, helping clients bring life-saving treatments to patients around the world. With a team of experienced professionals, P4A provides tailored solutions to optimize pricing, reimbursement, and market access strategies.
For more information on Sophie Schmitz’s attendance at the Cell & Gene Meeting on the Mesa 2024 or to schedule a meeting with P4A during the event, please contact:
Contact: Partners4Access
Email: [email protected]
Website: www.partners4access.com
